TABLE III. Median Survival by Kaplan–Meier Estimate for Comorbidity.
| Comorbidity | Total no. patients | Death N (%) | Median survival (mo) | 95% CI | P (univariate) |
|---|---|---|---|---|---|
| Cardiovascular disease | <0.001 | ||||
| Yes | 328 (55) | 239 (73) | 16.4 | 12.6–20.2 | |
| No | 272 (45) | 153 (56) | 30.8 | 22.6–39 | |
| Other malignancy | <0.001 | ||||
| Yes | 168 (28) | 120 (71) | 13.1 | 8.8–17.4 | |
| No | 432 (72) | 272 (63) | 25.7 | 21.9–29.5 | |
| Endocrine | 0.009 | ||||
| Yes | 97 (16) | 73 (75) | 19.7 | 12.4–27 | |
| No | 503 (84) | 319 (63) | 23.4 | 19.9–26.9 | |
| Respiratory | 0.37 | ||||
| Yes | 53 (9) | 42 (79) | 21.9 | 10.4–33.4 | |
| No | 547 (91) | 350 (64) | 22.4 | 19.5–25.3 | |
| Psychiatric | 0.36 | ||||
| Yes | 53 (9) | 32 (60) | 29.8 | 16.9–42.7 | |
| No | 552 (92) | 360 (65) | 22.1 | 18.7–25.5 | |
| Gastrointestinal | 0.05 | ||||
| Yes | 40 (7) | 31 (78) | 19.7 | 10.4–29 | |
| No | 560 (93) | 361 (64) | 22.4 | 19.6–25.2 | |
| Neurologic | 0.43 | ||||
| Yes | 35 (6) | 25 (71) | 26.6 | 3–50.2 | |
| No | 564 (94) | 367 (65) | 22.2 | 19.2–25.2 | |
| Renal | 0.07 | ||||
| Yes | 14 (2) | 11 (79) | 11.8 | 0–25.7 | |
| No | 586 (98) | 381 (65) | 22.4 | 19.6–25.2 | |
| Reumathologic | 0.51 | ||||
| Yes | 17 (3) | 9 (53) | 14 | 6.3–21.7 | |
| No | 583 (97) | 383 (66) | 22.2 | 19.6–24.8 | |
| Substance abuse | 0.61 | ||||
| Yes | 32 (5) | 22 (63) | 23.1 | 4.4–41.8 | |
| No | 568 (95) | 370 (65) | 22.2 | 19.5–24.9 | |
| Obesity | 0.61 | ||||
| Yes | 1 (0.7) | 1 (100) | 75 | NR | |
| No | 599 (99) | 391 (65) | 22.2 | 19.2–25.2 | |
| Immunologic | 0.67 | ||||
| Yes | 1 (0.7) | 0 | NA | NA | |
| No | 599 (99) | 392 (65) | 22.2 | 19.2–25.2 |
Abbreviations: CI, confidence interval.